These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 6243720)
1. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses. Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720 [TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease. Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226 [TBL] [Abstract][Full Text] [Related]
3. The leukocyte migration inhibition response to certain breast cancer-related antigens (MCF-7 and MuMTV): their potential as discriminants. Wanebo HJ; Fukuda M; Tsuei L; Sarkar N; Ashikari H Surgery; 1979 Aug; 86(2):275-83. PubMed ID: 462374 [TBL] [Abstract][Full Text] [Related]
4. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers. Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925 [TBL] [Abstract][Full Text] [Related]
5. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients. Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532 [No Abstract] [Full Text] [Related]
6. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840 [TBL] [Abstract][Full Text] [Related]
7. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts. Rudczynski AB; Dyer CA; Mortensen RF Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103 [No Abstract] [Full Text] [Related]
8. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer. Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639 [TBL] [Abstract][Full Text] [Related]
9. Geographic and family studies of immunological responses to antigens of the murine mammary tumor virus in sera of patients with breast cancer. Day NK; Witkin SS; Sarkar NH; Kinne D; Jussawalla DJ; Levin A; Hsia CC; Good RA Trans Assoc Am Physicians; 1980; 93():123-9. PubMed ID: 6264656 [TBL] [Abstract][Full Text] [Related]
10. Assessment of cellular immune response to cancer of the breast. Herberman RB Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763 [TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferative responses to mouse mammary tumor virus in lymphocyte subsets of breast cancer patients. Lopez DM; Parks WP; Silverman MA; Distasio JA J Natl Cancer Inst; 1981 Aug; 67(2):353-8. PubMed ID: 6267344 [TBL] [Abstract][Full Text] [Related]
12. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer. Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH Surg Forum; 1978; 29():167-9. PubMed ID: 233830 [No Abstract] [Full Text] [Related]
13. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations. Black MM; Zachrau RE; Shore B; Dion AS; Leis HP Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421 [No Abstract] [Full Text] [Related]
14. Responses of serum from breast cancer patients to murine mammary tumor virus: fact or artifact? Dion AS; Girardi AJ; Williams CC; Pomenti AA; Redfield ES J Natl Cancer Inst; 1987 Aug; 79(2):207-11. PubMed ID: 3037149 [TBL] [Abstract][Full Text] [Related]
15. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues. Zachrau RE; Black MM; Dion AS; Shore B; Williams CJ; Leis HP Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264 [No Abstract] [Full Text] [Related]
16. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer. Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696 [No Abstract] [Full Text] [Related]
17. Antibodies to MuMTV proteins in the sera of mammary carcinoma patients' healthy daughters. Litvinov S; Kryukova I; Hint E; Purde M Arch Geschwulstforsch; 1986; 56(6):407-12. PubMed ID: 3030219 [TBL] [Abstract][Full Text] [Related]
18. [Presence of antibodies specifically reacting with structural proteins of the mammary cancer virus among antibodies found in circulating immune complexes in patients with breast cancer]. Litvinov SV; Malivanova TF; Chuev IuV; Kriukova IN Biull Eksp Biol Med; 1988 Apr; 105(4):475-7. PubMed ID: 2833956 [TBL] [Abstract][Full Text] [Related]
19. Cellular antitumor immune response in women with risk factors for breast cancer. Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231 [TBL] [Abstract][Full Text] [Related]
20. Early detection of breast cancer by leukocyte adherence inhibition assay. Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]